Federated Hermes, Inc. Acorda Therapeutics Inc Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.67 $226 - $1,260	-755 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.61 - $2.5 $157,823 - $245,067	-98,027 Reduced 99.24%	755 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.3 - $4.71 $683 - $1,398	297 Added 0.3%	98,782 $236,000
Q3 2021 Nov 15, 2021	SELL	$3.36 - $4.79 $21,272 - $30,325	-6,331 Reduced 6.04%	98,485 $453,000
Q2 2021 Aug 16, 2021	SELL	$3.61 - $5.23 $6,562 - $9,508	-1,818 Reduced 1.7%	104,816 $500,000
Q1 2021 May 13, 2021	BUY	$3.8 - $8.04 $405,209 - $857,337	106,634 New	106,634 $519,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.